Nicole Lossnitzer1, Wolfgang Herzog2, Jobst Hendrik Schultz2, Tobias Taeger3, Lutz Frankenstein3, Beate Wild2. 1. Department of General Internal Medicine and Psychosomatics, University of Heidelberg, Heidelberg, Germany. Electronic address: Nicole.Lossnitzer@med.uni-heidelberg.de. 2. Department of General Internal Medicine and Psychosomatics, University of Heidelberg, Heidelberg, Germany. 3. Department of Cardiology, University of Heidelberg, Heidelberg, Germany.
Abstract
OBJECTIVE: To date, very little is known about the specific needs of patients with chronic heart failure (CHF) who must cope with depression. We therefore questioned CHF patients reporting depressive symptoms about their concerns and preferences regarding various psychosocial treatment options. After three-month, we determined how many patients had actually participated in a treatment. METHODS: 85 patients with CHF fulfilling the criteria of a depressive disorder according to the PHQ-9 were investigated. Data were analyzed using descriptive and frequency, as well as logistic regression analyses. RESULTS: 64.7% of the sample reported that they could envision adhering to supportive talks at longer intervals, whereas only 34.1% would accept an antidepressant. After three months, 24.7% of the patients had actually participated in a treatment. Generalized anxiety severity (GAD-7) was very closely associated with treatment preferences and treatment utilization: The higher the generalized anxiety severity, the more likely was the patients' disposition to begin an antidepressant and/or psychotherapy. CONCLUSIONS: The most favoured treatment option was a low-threshold service with supportive talks. PRACTICE IMPLICATIONS: Future studies investigating the improvement of patient-centred care in CHF patients should include measurements of generalized anxiety.
OBJECTIVE: To date, very little is known about the specific needs of patients with chronic heart failure (CHF) who must cope with depression. We therefore questioned CHFpatients reporting depressive symptoms about their concerns and preferences regarding various psychosocial treatment options. After three-month, we determined how many patients had actually participated in a treatment. METHODS: 85 patients with CHF fulfilling the criteria of a depressive disorder according to the PHQ-9 were investigated. Data were analyzed using descriptive and frequency, as well as logistic regression analyses. RESULTS: 64.7% of the sample reported that they could envision adhering to supportive talks at longer intervals, whereas only 34.1% would accept an antidepressant. After three months, 24.7% of the patients had actually participated in a treatment. Generalized anxiety severity (GAD-7) was very closely associated with treatment preferences and treatment utilization: The higher the generalized anxiety severity, the more likely was the patients' disposition to begin an antidepressant and/or psychotherapy. CONCLUSIONS: The most favoured treatment option was a low-threshold service with supportive talks. PRACTICE IMPLICATIONS: Future studies investigating the improvement of patient-centred care in CHFpatients should include measurements of generalized anxiety.
Authors: Dariusz P Danel; Agnieszka E Siennicka; Pawel Fedurek; Tomasz Frackowiak; Piotr Sorokowski; Ewa A Jankowska; Boguslaw Pawlowski Journal: Am J Mens Health Date: 2017-02-13
Authors: Mirjam Dieckelmann; Juliana J Petersen; Corina Güthlin; Felix Reinhardt; Jasper Plath; Klaus Jeitler; Thomas Semlitsch; Ferdinand M Gerlach; Andrea Siebenhofer Journal: BMJ Open Date: 2020-10-10 Impact factor: 2.692